Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could fewer stents mean better recovery after a heart attack?

NCT ID NCT06353594

Disease control Sponsor: Hospital Universitario La Fe Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new approach using fewer stents and a drug-coated balloon to the standard method of placing stents in heart attack patients. About 1,272 participants will be randomly assigned to one of the two treatments. The goal is to see if the reduced-stent strategy lowers the risk of future heart problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,272 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2024

Expected to finish

Sep 2035

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- Patients presenting with STEMI and indication to undergo pPCI. Exclusion Criteria: * Life expectancy \<1 year due 1 to non-cardiac disease. * Inability to provide informed consent. * Cardiogenic shock. * Left ventricular ejection fraction \<15%. * Left main disease. * Stent thrombosis * Patients with prior bypass graft lesions requiring PCI (culprit or non culprit lesions). * Patients with chronic total occlusions. * Untreatable coronary disease. * Non-identified culprit lesion. * Known allergy to aspirin, ticagrelor, prasugrel, clopidogrel, paclitaxel or sirolimus.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ST elevation myocardial infarction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ST elevation myocardial infarction

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    23 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Complejo Hospitalario Universitario de A Coruña

    RECRUITING

    A Coruña, Spain

  • Complejo Hospitalario Universitario de Santiago de Compostela

    RECRUITING

    Santiago de Compostela, Spain

  • Consorcio Hospital General Universitario de Valencia

    RECRUITING

    Valencia, Spain

  • Consorcio Hospitalario Provincial de Castellon

    RECRUITING

    Castelló, Spain

  • Hospital Clinico Universitario Lozano Blesa

    RECRUITING

    Zaragoza, Spain

  • Hospital Clinico Universitario de Valladolid

    RECRUITING

    Valladolid, Spain

  • Hospital General Universitario de Elche

    RECRUITING

    Elche, Spain

  • Hospital Universitari Joan Xxiii de Tarragona

    RECRUITING

    Tarragona, Spain

  • Hospital Universitari de Bellvitge

    RECRUITING

    L'Hospitalet de Llobregat, Spain

  • Hospital Universitario Clínico San Cecilio

    RECRUITING

    Granada, Spain

  • Hospital Universitario Juan Ramón Jiménez

    RECRUITING

    Huelva, Huelva, Spain

  • Hospital Universitario La Paz

    RECRUITING

    Madrid, Spain

  • Hospital Universitario Miguel Servet

    RECRUITING

    Zaragoza, Spain

  • Hospital Universitario Mutua de Terrassa

    RECRUITING

    Terrassa, Spain

  • Hospital Universitario Puerta de Hierro Majadahonda

    RECRUITING

    Madrid, Spain

  • Hospital Universitario Regional de Malaga

    RECRUITING

    Málaga, Spain

  • Hospital Universitario Reina Sofía de Córdoba

    RECRUITING

    Córdoba, Spain

  • Hospital Universitario Virgen Del Rocio

    RECRUITING

    Seville, Spain

  • Hospital Universitario Y Politecnico La Fe

    RECRUITING

    Valencia, Valencia, Spain

  • Hospital Universitario de Burgos

    RECRUITING

    Burgos, Spain

  • Hospital Universitario de La Princesa

    RECRUITING

    Madrid, Spain

  • Hospital Universitario de Navarra

    RECRUITING

    Pamplona, Spain

  • Hospital de Mérida

    RECRUITING

    Mérida, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.